Tag Archive for: gene-editing technology

The agency’s staff reviewers said it was not clear if the limited donor cells used for assessment were adequate to evaluate the potential safety risks of the therapy.

Gene editing technologies are advancing rapidly in the clinic, with the potential first approval later this year, but challenges remain.

GSK’s chief scientist says an overhaul of the drugmaker’s R&D unit has begun delivering results and pledged a tighter focus than his predecessor on infectious disease and HIV.